Clinical Evaluation of the StablePoint Catheter and Force Sensing System for Paroxysmal Atrial Fibrillation
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
47 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- A.O. Krankenhaus Der Elisabethinen Linz
Linz, Austria
- Allgemeines Krankenhaus Akh
Vienna, Austria
- Onze Lieve Vrouw Ziekenhuis
Aalst, Belgium
- Vancouver General Hospital
Vancouver, British Columbia, Canada
- Hamilton General Hospital
Hamilton, Ontario, Canada
- Institut Universitaire de Cardiologie Et de Pneumologie de Quebec
Ste-Foy, Quebec, Canada
- Hospital de la Pitie-Salpetriere
Paris, France
- Immanuel Klinikum Bernau Herzzentrum Brandenburg
Bernau, Germany
- Queen Elizabeth Hospital
Kowloon, Hong Kong
- Prince of Wales Hospital
Shatin, Hong Kong
- Az. Osp. Lancisi
Ancona, AN, Italy
- Fondazione Centro San Raffaele
Milan, Italy
- Kokura Memorial Hospital
Fukuoka-ken, Japan
- Yokosuka Kyosai Hospital
Kanagawa, Japan
- Centre Hospitalier Princesse Grace
Monaco, Monaco
- Medisch Spectrum Twente
Amsterdam, Netherlands
- China Medical University Hospital
Taichung, Taiwan
- Taichung Veterans General Hospital
Taichung, Taiwan
- Taipei Veterans General Hospital
Taipei, Taiwan
- Papworth Hospital
Cambridge, United Kingdom
- Liverpool Heart and Chest Hospital
Liverpool, United Kingdom
- Freeman Hospital
Newcastle upon Tyne, United Kingdom
- Arrhythmia Research Group
Jonesboro, Arkansas, United States
- Adventhealth Orlando
Orlando, Florida, United States
- Sarasota Memorial Hospital
Sarasota, Florida, United States
- the Queen'S Medical Center
Honolulu, Hawaii, United States
- St. Lukes Idaho Cardiology Associates
Boise, Idaho, United States
- Loyola University Medical Center
Maywood, Illinois, United States
- St. John'S Hospital
Springfield, Illinois, United States
- University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
- Mercy Hospital Medical Center
West Des Moines, Iowa, United States
- University of Kansas Hospital
Kansas City, Kansas, United States
- Baptist Health Lexington
Lexington, Kentucky, United States
- University of Michigan Hospitals
Ann Arbor, Michigan, United States
- St. Mary'S Duluth Clinic Regional Heart Center
Duluth, Minnesota, United States
- Catholic Medical Center
Manchester, New Hampshire, United States
- Northwell Health
Bay Shore, New York, United States
- Weill Cornell Medical University
New York, New York, United States
- Wake Forest University School of Medicine
Winston-Salem, North Carolina, United States
- Bethesda North Hospital
Cincinnati, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Apr 2021
- Primary completion
- 21 Jun 2023
- Completion
- 21 Jun 2023
- Last update posted
- 16 Jan 2025
- Registered enrollment
- 321
- Registry id
- NCT04580914
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.